Description
Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
Article: Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
€2.42
Related products
-
Article: Highlights in squamous cell carcinoma of the head and neck
€2.42 Add to cart -
Article: Highlights in respiratory oncology
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
